Cellectis
CLLS
#8359
Rank
HK$2.24 B
Marketcap
HK$22.27
Share price
1.43%
Change (1 day)
12.59%
Change (1 year)

Cellectis (CLLS) - Total debt

Total debt on the balance sheet as of March 2026 : HK$0.67 Billion

According to Cellectis's latest financial reports the company's total debt is HK$0.67 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Cellectis - Total debt on balance sheet (from 2008 to 2026)

Total debt by year

Year Total debt Change
2025-12-31HK$0.70 B-0.58%
2024-12-31HK$0.71 B6.89%
2023-12-31HK$0.66 B12.21%
2022-12-31HK$0.59 B-24.73%
2021-12-31HK$0.78 B-4.89%
2020-12-31HK$0.82 B123.05%
2019-12-31HK$0.37 B3404.57%
2018-12-31HK$10.57 M3882.66%
2017-12-31HK$0.26 M-98.05%
2016-12-31HK$13.64 M-18.94%
2015-12-31HK$16.83 M-51.57%
2014-12-31HK$34.76 M-20.15%
2013-12-31HK$43.53 M-1.25%
2012-12-31HK$44.08 M-91.78%
2011-12-31HK$0.53 B2241.53%
2010-12-31HK$22.91 M66.48%
2009-12-31HK$13.76 M-1.88%
2008-12-31HK$14.02 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Regeneron Pharmaceuticals
REGN
HK$21.22 B 3,028.34%๐Ÿ‡บ๐Ÿ‡ธ USA
uniQure
QURE
HK$0.49 B-26.80%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
HK$2.31 B 241.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA